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Background: Little is known about the quality of life in patients with cervical dystonia, although pain
and depression are relatively common.
Objective: To test the hypothesis that an individual’s ability to cope with the disease will modify the
association of intrinsic, extrinsic, and disease related factors with quality of life.
Methods: Patients with cervical dystonia diagnosed by a movement disorder specialist were recruited
from seven European countries. Data on quality of life (SF-36), measures of coping, and intrinsic,
extrinsic, and disease related factors were collected by a self completed postal questionnaire.
Results: 289 patients (101 men and 188 women), mean age 55 years, completed the questionnaire.
Both physical and mental quality of life scores were predicted by self esteem and self deprecation, edu-
cational level, employment status, social support, response to botulinum toxin, disease severity, social
participation, stigma, acceptance of illness, anxiety, and depression. In multivariable analyses, the
strongest predictors were anxiety and depression. Severe depression was associated with a 19.1 point
decrement in the physical summary score (95% confidence interval, −31.7 to −6.6; p = 0.003); how-
ever, disease duration and severity remained predictors.
Conclusions: Care for patients with cervical dystonia must not only focus on reducing the severity of
the dystonia but also on the psychological wellbeing of the patient. Interventions aimed at treating
depression or anxiety, especially of a cognitive nature, may have a large impact on improving quality
of life.
Primary cervical dystonia is the commonest form of focaldystonia. It is defined as twisting or turning of the neck,or displacement of the head, caused by involuntary mus-
cle contractions. Onset of cervical dystonia is in adult life,
usually between the fourth and sixth decades, and women are
affected 1.5 to 1.9 times more often than men.1 Symptoms
develop slowly, with pulling or tugging in the neck or twisting
or jerking of the head. Head tremor is also common.
Epidemiological data on the prevalence of cervical dystonia
are sparse. Studies from Europe and the USA have found
prevalences of between 57 and 90 per million, although in
Finland the figure was much higher, at 233 per million.2 3
There is little published information on the impact of cervical
dystonia on the quality of life and what factors may modify a
patient’s ability to cope with this disease.4 5 Unlike other forms
of focal dystonia, pain is a predominant feature and is
reported in up to 75% of patients,6 while depression has been
documented in 24% of patients.5
We have reported previously that cervical dystonia had a
significant impact on the quality of life as assessed by the
short form 36 (SF-36) generic quality of life measure,7 and the
impact was comparable to that of more serious neurological
conditions (multiple sclerosis, Parkinson’s disease, stroke).
Although patients with cervical dystonia had the best physical
function score, they scored worst for mental health and emo-
tional role limitation. They also rated their energy and vitality,
physical role limitation, and social function significantly
worse than either Parkinson’s disease patients or long term
survivors of stroke. The reasons for this large negative effect
were not clear. In addition, some patients were able to cope
well with the disease, with relatively little deterioration in
their quality of life.
In this study we examined whether differences in reported
quality of life among cervical dystonia patients can be
explained by intrinsic (for example, premorbid and demo-
graphic), extrinsic (social environment), and disease related
variables (severity, duration).We hypothesised that the way in
which individuals respond to their disease is a key intermedi-
ary between explanatory variables and the quality of life.
METHODS
Patients with primary or idiopathic cervical dystonia were
identified by the ESDE Collaborative Group.1 2 All patients
were diagnosed by a movement disorder specialist from seven
European countries (listed at the end of the article). Patients
with secondary dystonia were excluded.
Patients received a postal questionnaire containing a range
of questions, including the SF-36 and various other measures
of psychological health, social participation, and support (see
below). The questionnaire was translated and back translated
for every language to ensure accuracy and comparability.
Completed questionnaires were returned and data collated on
a central database for analysis.
Outcome measure
Our outcome measure for quality of life was the SF-36,8 a vali-
dated health status measure with eight areas—four physical
and four emotional—that cover activities of daily living, emo-
tional state, pain, fatigue, social participation, and perceptions
of health. A higher score indicates a better quality of life. The
items can be summed to give scores out of 100. In addition, the
various areas can be aggregated to generate a physical and
mental summary score out of 100.
Explanatory and intermediary variables
On the basis of past knowledge and experience, we proposed
that quality of life would be determined by a variety of differ-
ent domains (fig 1).
Intrinsic factors were variables that were either demographic
(age, sex) or reflected premorbid personality characteristics
(self esteem, self deprecation). Self esteem and a tendency to
self deprecate were measured by the Rosenberg self esteem
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scale,9 which has been used in dystonia, Parkinson’s disease,
and other neurological conditions. It contains 10 statements,
five of which cover self esteem and five self deprecation. Each
response is scored from 0 to 4 according to the strength of
agreement, producing scores out of 20 for the two domain
scores. Low scores indicate low self esteem or a high degree of
self deprecation.
Extrinsic factors included aspects of an individual’s social
environment such as social support, cohabiting, and socioeco-
nomic status. The quantity and quality of support from
partners, friends, and family were measured using the multi-
dimensional personal support scale.10 Each source of support
was assessed in four dimensions. The respondent could rate
their level of satisfaction with support received in each
dimension on a scale of 0 to 7. The highest possible score was
84, which indicated complete satisfaction with the support
received from all sources. We used a composite educational
variable because of the problems of classifying socioeconomic
status across different countries and cultures (left school at
“minimum” age, stayed on at school for “further” education,
obtained “degree” or equivalent professional qualification).
Disease related factors included disease duration, self rated
severity (0–10 point scale; a higher score indicates more severe
disease) and reported response to botulinum toxin (better,
worse, or unchanged).
The above factors were viewed as explanatory variables that
could interact in a complex way and determine how an indi-
vidual copes with a disease.
Coping behaviour was seen as an intermediary domain that
mediated the relation between the explanatory variables and
the quality of life outcome measure. Coping was assessed in
various ways: acceptance of illness, stigma, social participa-
tion, anxiety, and depression.
Acceptance of illness was measured using the acceptance of
illness scale,11 which was developed for use in chronic illnesses
such as diabetes and rheumatoid arthritis. The scale contains
eight statements (for example, “I have difficulty accepting my
illness”) with which the respondent is invited to agree or
disagree. Each response is scored from 1 to 5 according to the
strength of agreement, with the exception of the last question
where the marking order is reversed. The total score of 40 was
reported, divided by 8 to enable comparison with the other
chronic conditions. Higher scores indicated a lower acceptance
of illness.
Experience of stigma was measured using the stigma
scale,12 which was developed for survivors of bowel cancer.
There are six general statements that relate to the respond-
ent’s self image and relationships with others (for example, “I
avoid other people”) and these are scored from 0 to 3 accord-
ing to the strength of agreement. The scores were grouped
Figure 1 Conceptual scheme of the influence of intrinsic, extrinsic, and disease related factors and coping abilities on the quality of life in
cervical dystonia.
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Table 1 Description of explanatory, intermediary,
and outcome variables by sex
Variable
Men
(n=101)
Women
(n=188) All (n=289)
Categorical variables
Cohabiting (%) 66 (66.0) 128 (68.1) 194 (67.4)
Educational level (%)
Minimum 48 (47.5) 92 (48.9) 140 (48.4)
Further 25 (24.8) 66 (35.1) 91 (31.5)
Higher 28 (27.7) 30 (16.0) 58 (20.1)
Employment status (%)
Employed 38 (37.6) 53 (28.2) 91 (31.5)
Retired 45 (44.6) 81 (43.1) 126 (43.6)
Other 18 (17.8) 54 (28.7) 72 (24.9)
Response to botulinum toxin (%)
Improved 67 (72.8) 119 (78.8) 186 (76.5)
Continuous variables*
Age (years) 52.8 (14.3) 56.7 (12.5) 55.3 (13.2)
Disease duration (years) 11.6 (8.2) 12.0 (9.3) 11.9 (8.9)
Global severity (1=best,
10=worst)
5.7 (2.2) 5.7 (2.2) 5.7 (2.2)
Stigma score 7.0 (3.9) 7.9 (4.0) 7.6 (4.0)
Acceptance of illness 2.76 (1.09) 2.60 (0.98) 2.66 (1.02)
Social participation 34.9 (10.7) 33.3 (10.5) 33.9 (10.6)
Social support 57.1 (17.6) 57.2 (19.2) 57.1 (18.6)
Beck anxiety score 13.1 (9.3) 16.1 (12.4) 15.0 (11.5)
Beck depression score 10.4 (7.5) 12.8 (9.7) 12.0 (9.0)
Self esteem 14.5 (2.6) 14.0 (2.8) 14.2 (2.7)
Self deprecation 10.1 (3.3) 11.0 (3.4) 10.7 (3.4)
Physical summary score 52.9 (21.4) 46.3 (22.0) 48.7 (21.9)
Mental summary score 58.8 (20.6) 53.4 (22.4) 55.4 (21.9)
*These values are mean (SD).
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using the recommended cut off points, where a score of more
than 12 indicates severe stigma.
The level of social participation was measured with the lei-
sure activities scale,13 which lists 27 common leisure activities.
Respondents score from 0 to 3 on each activity, according to
their level of participation. The maximum possible score is 81,
indicating a high level of social participation.
Anxiety was measured with the Beck anxiety index.14 The
scale contains a list of 21 common symptoms of anxiety that
are scored from 0 to 3 according to how frequently the
respondent experiences them. The highest possible score is 63,
indicating disabling levels of anxiety.
Depression was measured with the Beck depression
inventory.15 The scale contains 21 questions with four possible
responses. The highest possible score is 63. Increasing scores
indicate a progressively more severe level of depression, from
no depression (0 to 4), through mild depression (5 to 13) and
moderate depression (14 to 20), to severe depression (21 and
above).
Statistical methods
Comparison between groups was undertaken either by analy-
sis of variance or by χ2 tests. Multiple least squares linear
regression was used to examine predictors of the outcome
measures. Assumptions of normality were tested using stand-
ard diagnostics and examining the scatterplot of residuals
against fitted values. Continuous and discrete explanatory
variables were transformed where appropriate and changed
into z scores to enable direct comparison of the β coefficients.
In some cases, they had to be categorised owing to extreme
skewness, which remained even after transformation. Cat-
egorical terms were modelled as both dummy and ordinal
variables. For continuous explanatory variables, we tested
assumptions of linearity by repeating our models with the
addition of a quadratic term. All significance tests are two
sided at conventional levels of significance (p < 0.05).
RESULTS
Data were collected on 289 patients (101 men and 188
women), mean age 55 years. The average response rate was
75% across all centres. The basic descriptive data are presented
in table 1. Around one third of the sample was living alone.
Women were slightly older, with longer disease duration,
lower educational status, and higher scores for both anxiety
and depression, but there was little if any sex difference in
most of the other variables. Women scored worse for both
physical and mental summary scores.
Most of the explanatory and all the intermediary variables
showed statistically significant associations with both the
physical and the mental summary scores after adjustment for
age and sex (table 2). Intrinsic personality factors were highly
Table 2 Age and sex adjusted associations of explanatory and intermediary
variables with physical and mental summary scores
Variable Physical summary score Mental summary score
β Value 95% CI p Value β Value 95% CI p Value
Intrinsic factors
Age (years)
40–49* −7.5 −17.0 to 2.0 −7.5 −17.1 to 2.0
50–59 −7.0 −16.5 to 2.4 −3.4 −12.9 to 6.1
60–69 −7.2 −16.8 to 2.4 −5.7 −15.5 to 4.0
70+ −13.8 −24.2 to −3.3 0.15† −4.6 −15.2 to 5.9 0.51†
Women −6.1 −11.7 to −0.5 0.03 −5.5 −11.2 to 0.2 0.06
Self esteem 11.7 9.4 to 14.1 <0.001 13.1 10.9 to 15.3 <0.001
Self deprecation −9.0 −11.6 to −6.5 <0.001 −10.9 −13.3 to −8.4 <0.001
Extrinsic factors
Single v cohabiting 2.9 −3.0 to 8.7 0.33 2.2 −3.7 to 8.0 0.47
Educational level
Further 4.9 −1.2 to 11.0 0.11 9.1 3.0 to 15.2 0.004
Higher 9.4 2.4 to 16.5 0.009 3.4 −3.7 to 10.5 0.35
Employment status
Retired −17.1 −24.6 to −9.7 <0.001 −14.4 −21.8 to −6.9 <0.001
Other −12.3 −19.7 to −5.0 0.001 −15.6 −23.0 to −8.1 <0.001
Social support 4.8 2.1 to 7.6 0.001 6.1 3.4 to 8.9 <0.001
Disease related factors
Disease duration (years)
6–10 −1.3 −8.8 to 6.1 0.73 3.0 −4.5 to 10.6 0.43
11–16 4.2 −3.9 to 12.3 0.31 3.1 −5.0 to 11.3 0.76
17+ 5.3 −2.6 to 13.2 0.19 8.5 0.6 to 16.5 0.04
Response to botulinum toxin
No benefit −8.2 −15.1 to −1.4 0.01 −7.7 −14.7 to −0.8 0.03
Global severity −12.2 −14.6 to −9.9 <0.001 −11.1 −13.6 to −8.7 <0.001
Intermediary variables
Social participation 7.1 4.6 to 9.6 <0.001 8.5 6.1 to 11.0 <0.001
Stigma −10.0 −12.7 to −7.4 <0.001 −12.0 −14.5 to −9.5 <0.001
Acceptance of illness −8.2 −10.7 to −5.7 <0.001 −7.4 −10.0 to −4.9 <0.001
Anxiety
Mild −15.9 −21.3 to −10.6 <0.001 −18.0 −23.0 to −12.9 <0.001
Moderate −22.8 −29.2 to −16.4 <0.001 −27.3 −33.4 to −21.2 <0.001
Severe −35.1 −43.0 to −27.3 <0.001 −38.7 −46.1 to −31.3 <0.001
Depression
Mild −19.9 −25.9 to −14.0 <0.001 −19.7 −25.2 to −14.3 <0.001
Moderate −29.4 −36.3 to −22.4 <0.001 −33.6 −39.9 to −27.2 <0.001
Severe −43.3 −51.0 to −35.7 <0.001 −48.3 −55.3 to −41.3 <0.001
*Relative to 20–39 year baseline group.
†p Value from heterogeneity test for age group.
CI, confidence interval.
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predictive. These personality factors were more strongly associ-
ated with mental health, but the differences were not large.
Women scored worse than men on both outcomes. The oldest
age group scored worse on the physical summary score, but
otherwise there was no real age effect. All the extrinsic factors
were predictive except for cohabiting status, although higher
levels of social support were associated with better physical and
mental summary scores. Subjects with a higher educational
level also seemed to have better scores, although this trend was
not consistent. Patients who reported no benefit from botuli-
num toxin had worse global severity and were found to have
lower physical and mental summary scores. A longer duration
of disease severity was associated with better scores.
Intermediary variables tended to show stronger associa-
tions. Not surprisingly both anxiety and depression were
highly predictive of worse mental scores but perhaps less
obvious was the fact that this association was almost as strong
with the physical summary score. As predicted, less social
participation, more stigma, and less acceptance of illness were
all highly predictive of worse mental and physical scores.
In multivariable analyses, many of the explanatory vari-
ables for the physical summary score were markedly
attenuated (table 3). Sex, educational level, social support, and
response to botulinum toxin were all no longer statistically
significant. Self esteem, self deprecation, retired status, and
patient severity score remained significant predictors but with
weaker effect estimates. The beneficial effect of disease dura-
tion was increased after multivariable adjustment,with a clear
trend effect (p < 0.001). Further adjustment for the interme-
diary variables weakened the effects of most of the
explanatory variables, although disease duration and patient
severity remained significant predictors. The largest effect
sizes were for the severity of anxiety and depression, the latter
having a greater negative effect on physical score.
Similar findings were seen with the mental summary score
(table 4). Again, disease duration and severity score were the
best predictors, but self deprecation and poor social support
were also predictors of worse mental scores. After adjustment
for intermediary variables, cohabiting status, self deprecation,
disease duration, and patient severity score continued to have
a significant association, but anxiety and depression scores
showed larger effects.
DISCUSSION
This is the first study to examine a comprehensive range of fac-
tors that could explain quality of life in patients with cervical
Table 3 Multivariable associations between explanatory variables, with and without
adjustment for intermediary variables, and physical summary score
Physical summary score
Adjusted for other intrinsic, extrinsic, and
disease related factors Adjusted for all variables
Variable β Value 95% CI p Value β Value 95% CI p Value
Intrinsic factors
Age (years)
40–49* −3.3 −11.4 to 4.9 −0.9 −9.0 to 7.2
50–59 5.0 13.3 to 3.3 −4.6 −12.8 to 3.5
60–69 0.1 −9.1 to 9.3 −0.3 −9.4 to 8.7
70+ −6.1 −16.1 to 3.8 0.39† −7.7 −17.5 to 2.2 0.25†
Women −2.6 −7.7 to 2.5 0.32 −3.2 −8.1 to 1.8 0.21
Self esteem 3.7 0.5 to 6.8 0.02 1.2 −1.9 to 4.4 0.44
Self deprecation −5.2 −8.0 to −2.5 <0.001 −1.1 −4.0 to 1.9 0.48
Extrinsic factors
Single v cohabiting −2.6 −7.7 to 2.6 0.32 −3.3 −8.4 to 1.9 0.22
Educational level
Further −1.7 −7.2 to 3.7 0.53 −3.9 −9.3 to 1.5 0.16
Higher 3.2 −2.7 to 9.2 0.28 4.8 −1.1 to 10.7 0.11
Employment status
Retired −7.7 −14.3 to −1.2 0.02 −5.6 −12.0 to 0.9 0.09
Other −3.3 −10.0 to 3.5 0.34 −1.5 −7.9 to 4.9 0.64
Social support 2.0 −0.6 to 4.6 0.13 1.4 −1.2 to 4.0 0.30
Disease related factors
Disease duration (years)
6–10 2.5 −3.7 to 8.7 0.43 2.5 −3.3 to 8.4 0.39
11–16 8.0 1.1 to 14.9 0.02 7.0 0.2 to 13.7 0.04
17+ 11.1 4.3 to 17.9 0.002 8.5 1.8 to 15.3 0.01
Response to botulinum toxin
No benefit 0.5 −5.6 to 6.7 0.86 1.9 −4.2 to 7.9 0.55
Global severity −8.7 −11.4 to −5.9 <0.001 −6.1 −8.9 to −3.3 <0.001
Intermediary variables
Social participation −0.0 −2.6 to 2.5 0.99
Stigma −1.5 −4.6 to 1.6 0.34
Acceptance of illness −2.0 −4.5 to 0.5 0.12
Anxiety
Mild −7.4 −13.1 to −1.8 0.01
Moderate −6.8 −14.0 to 0.4 0.07
Severe −12.2 −22.4 to −2.0 0.02
Depression
Mild −10.4 −17.7 to −3.2 0.005
Moderate −13.9 −23.5 to −4.3 0.005
Severe −19.1 −31.7 to −6.6 0.003
*Relative to 20–39 year baseline group.
†p Value from heterogeneity test for age group.
CI, confidence interval.
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dystonia. While patients reported worse quality of life for the
physical summary score, the mental health score was also strik-
ingly reduced compared with the general population.16 This
marked effect on mental wellbeing may reflect the obvious stig-
matising effect of living with such a visible disorder. Not surpris-
ingly, the severity of the condition and whether the patient
showed a response to botulinum toxin both predicted quality of
life. However, intrinsic personality features (self esteem, self
deprecation) and educational status also modified the patients’
ability to cope with the disease. Longer disease duration was
associated with better quality of life, which is probably related to
the development of successful coping strategies. We had an a
priori hypothesis that an individual’s ability to get on with their
life, despite their disease, would influence their social participa-
tion, perceptions of stigma, and acceptance of illness, as well as
feelings of anxiety and depression. These intermediary variables
were all highly significant predictors of quality of life and were
stronger than the intrinsic, extrinsic, and disease related factors.
In our final models, most of the significant variables were no
longer predictive. This suggests that their initial predictive effect
was mediated mainly through psychological processes such as
depression and anxiety, though disease duration and severity
remained predictors.
Study limitations
It is important to consider the limitations of our study. First,
all patients were recruited from specialist centres. This
enhances the validity of the diagnosis but reduces the gener-
alisability of our findings as our patients are unlikely to be
typical of patients with cervical dystonia in general. Second,
while our response rate wasmoderately high, it is possible that
patients with severe depression were more likely to fail to
complete the questionnaire. Exclusion of such patients will
not bias our findings unless the associations between
exposure and outcome variables differed in this subgroup
compared with the rest of the study sample. Third, many of
the variables we tried to test in our model will be measured
imprecisely using relatively crude questionnaire data. It is
therefore important to appreciate that independent effects
seen in multivariable models may be misleading if the degree
of imprecision varies across exposures.17 18
Quality of life in comparable conditions
The factors that influence quality of life have been studied in
other, comparable conditions.
In multiple sclerosis, perceptions of social support and self
efficacy were important predictors of adaptation to the
Table 4 Multivariable associations between explanatory variables, with and without
adjustment for intermediary variables, and mental summary score
Mental summary score
Adjusted for other intrinsic, extrinsic,
and disease related factors Adjusted for all variables
Variable β Value 95% CI p Value β Value 95% CI p Value
Intrinsic factors
Age (years)
40–49* −5.0 −12.8 to 2.7 −5.3 −12.7 to 2.1
50–59 −2.9 −10.9 to 5.0 −3.9 −11.3 to 3.5
60–69 −0.3 −9.1 to 8.5 −2.9 −11.2 to 5.4
70+ 1.6 −8.0 to 11.2 0.49† −1.4 −10.5 to 7.6 0.66†
Women −1.8 −6.6 to 3.1 0.48 −1.9 −6.4 to 2.7 0.42
Self esteem 4.6 −6.6 to 3.1 0.48 1.5 −1.4 to 4.4 0.30
Self deprecation −6.7 −9.3 to −4.1 0.003 −2.8 −5.5 to −0.1 0.04
Extrinsic factors
Single v cohabiting −4.2 −9.2 to 0.7 0.09 −5.0 −9.8 to −0.3 0.04
Educational level
Further 1.0 −4.2 to 6.2 0.71 −0.4 −5.3 to 4.6 0.89
Degree −2.2 −7.9 to 3.5 0.44 −0.7 −6.1 to 4.7 0.79
Employment status
Retired −4.4 −10.7 to 1.8 0.17 −2.5 −8.5 to 3.3 0.39
Other −4.0 −10.5 to 2.4 0.22 −2.6 −8.5 to 3.2 0.38
Social support 2.8 0.3 to 5.3 0.03 2.1 −0.3 to 4.5 0.08
Disease related factors
Disease duration (years)
6–10 6.8 0.8 to 12.7 0.03 6.8 1.5 to 12.2 0.01
11–16 6.6 0.1 to 13.2 0.05 5.4 −0.7 to 11.6 0.08
17+ 13.5 7.0 to 20.1 <0.001 11.0 4.8 to 17.1 0.001
Response to botulinum toxin
No benefit −0.9 −6.8 to 5.0 0.77 −0.5 −6.1 to 5.0 0.85
Global severity −7.4 −10.1 to −4.8 <0.001 −5.1 −7.7 to −2.6 <0.001
Intermediary variables
Social participation −0.4 −2.7 to 1.9 0.72
Stigma −1.4 −4.3 to 1.4 0.32
Acceptance of illness 0.1 −2.2 to 2.5 0.91
Anxiety
Mild −9.9 −15.1 to −4.8 <0.001
Moderate −13.2 −19.8 to −6.5 <0.001
Severe −18.7 −28.0 to −9.4 <0.001
Depression
Mild −9.6 −16.2 to −3.0 0.005
Moderate −15.6 −24.4 to −6.8 0.001
Severe −16.1 −27.6 to −4.6 0.006
*Relative to 20–39 year baseline group.
†p Value from heterogeneity test for age group.
CI, confidence interval.
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illness.19–21 Self efficacy (defined as the ability to control
negative thoughts) was a far stronger predictor of mood and
social activity than the clinical variables.
Studies of stroke are generally consistent with our observa-
tions. One study found that subjective wellbeing after stroke
(defined as “satisfaction,” “strength,” “calmness,” and “cheer-
fulness”) was related to female sex, older age, good general
and mental health, and a strong social network.22 Similarly
two studies measuring handicap and quality of life after a
stroke found that these outcomes were related to perception of
control and social support23 as well as depression.24
In rheumatoid arthritis, anxiety and depression were found
to be stronger predictors of pain than clinical variables.25 26 The
ability to continue working after the onset of the disease was
significantly related to lower reports of pain and depression,
irrespective of disease severity.27 Low self efficacy and a
perception of helplessness were also predictors of
disability,28 29 as was a low level of formal education.30 While
disability was the main predictor of depression among
rheumatoid arthritis patients, sex, disease duration, social iso-
lation, and economic deprivation were also important factors.
Recent studies of Parkinson’s disease emphasise the effect
of depression of quality of life.31–33 However, its effects can be
mitigated by having a sense of “mastery” (measured by “locus
of control” and “self efficacy”) over the condition34 and using
active coping strategies.35 “Mastery” was also an important
mediator between disease severity and quality of life in
epilepsy.36
As in dystonia, fatigue and depression had an inverse rela-
tion with quality of life in epilepsy.37 Seizure frequency
appeared to be the main determinant, however, and patients
whose condition was controlled by surgery or drug treatment
reported quality of life scores similar to the general
population.38–40
Conclusions
Our results are similar to those found in other diseases where
psychosocial variables are important in either mediating or
modifying the effects of disease severity on the quality of life.
The ability to reduce disease severity through pharmacological
or other interventions will have a major benefit on both physi-
cal and mental wellbeing in patients with cervical dystonia.
However, there is a clear need to recognise and treat patients
with anxiety and depression. Given the marked role of other
psychological factors—such as self deprecation and accept-
ance of the illness—cognitive or other types of psychological
therapy should be considered as well as conventional drug
treatment, as on the basis of our results the former may have
more lasting beneficial effects. Increased social support either
through family or patient support groups may have some
additional benefit for mental wellbeing.
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